{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:42:02Z","timestamp":1794962522933,"version":"4.9.1"},"reference-count":54,"publisher":"American Association for Cancer Research (AACR)","issue":"17","funder":[{"DOI":"10.13039\/100001445","name":"Alex's Lemonade Stand Foundation","doi-asserted-by":"crossref","award":["GR-000000165"],"award-info":[{"award-number":["GR-000000165"]}],"id":[{"id":"10.13039\/100001445","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R35CA210064"],"award-info":[{"award-number":["R35CA210064"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P01 CA104838"],"award-info":[{"award-number":["P01 CA104838"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R35 CA197602"],"award-info":[{"award-number":["R35 CA197602"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["CA134743"],"award-info":[{"award-number":["CA134743"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["CA215059"],"award-info":[{"award-number":["CA215059"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007161","name":"Boston University","doi-asserted-by":"publisher","award":["1UL1TR001430"],"award-info":[{"award-number":["1UL1TR001430"]}],"id":[{"id":"10.13039\/100007161","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG-17-204-01-TBG"],"award-info":[{"award-number":["RSG-17-204-01-TBG"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>High-risk neuroblastoma remains therapeutically challenging to treat, and the mechanisms promoting disease aggression are poorly understood. Here, we show that elevated expression of dihydrolipoamide S-succinyltransferase (DLST) predicts poor treatment outcome and aggressive disease in patients with neuroblastoma. DLST is an E2 component of the \u03b1-ketoglutarate (\u03b1KG) dehydrogenase complex, which governs the entry of glutamine into the tricarboxylic acid cycle (TCA) for oxidative decarboxylation. During this irreversible step, \u03b1KG is converted into succinyl-CoA, producing NADH for oxidative phosphorylation (OXPHOS). Utilizing a zebrafish model of MYCN-driven neuroblastoma, we demonstrate that even modest increases in DLST expression promote tumor aggression, while monoallelic dlst loss impedes disease initiation and progression. DLST depletion in human MYCN-amplified neuroblastoma cells minimally affected glutamine anaplerosis and did not alter TCA cycle metabolites other than \u03b1KG. However, DLST loss significantly suppressed NADH production and impaired OXPHOS, leading to growth arrest and apoptosis of neuroblastoma cells. In addition, multiple inhibitors targeting the electron transport chain, including the potent IACS-010759 that is currently in clinical testing for other cancers, efficiently reduced neuroblastoma proliferation in vitro. IACS-010759 also suppressed tumor growth in zebrafish and mouse xenograft models of high-risk neuroblastoma. Together, these results demonstrate that DLST promotes neuroblastoma aggression and unveils OXPHOS as an essential contributor to high-risk neuroblastoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>These findings demonstrate a novel role for DLST in neuroblastoma aggression and identify the OXPHOS inhibitor IACS-010759 as a potential therapeutic strategy for this deadly disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-20-2153","type":"journal-article","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T12:57:22Z","timestamp":1625662642000},"page":"4417-4430","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Metabolic Enzyme DLST Promotes Tumor Aggression and Reveals a Vulnerability to OXPHOS Inhibition in High-Risk Neuroblastoma"],"prefix":"10.1158","volume":"81","author":[{"given":"Nicole M.","family":"Anderson","sequence":"first","affiliation":[{"name":"1Abramson Family Cancer Research Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania."},{"name":"2Department of Cell and Developmental Biology, University of Pennsylvania, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Qin","sequence":"additional","affiliation":[{"name":"3Departments of Pharmacology and Medicine, Section of Hematology and Medical Oncology, The Center for Cancer Research, Boston University School of Medicine, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7706-1643","authenticated-orcid":false,"given":"Jennifer M.","family":"Finan","sequence":"additional","affiliation":[{"name":"1Abramson Family Cancer Research Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lam","sequence":"additional","affiliation":[{"name":"3Departments of Pharmacology and Medicine, Section of Hematology and Medical Oncology, The Center for Cancer Research, Boston University School of Medicine, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Athoe","sequence":"additional","affiliation":[{"name":"3Departments of Pharmacology and Medicine, Section of Hematology and Medical Oncology, The Center for Cancer Research, Boston University School of Medicine, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rindert","family":"Missiaen","sequence":"additional","affiliation":[{"name":"1Abramson Family Cancer Research Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Skuli","sequence":"additional","affiliation":[{"name":"1Abramson Family Cancer Research Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Kennedy","sequence":"additional","affiliation":[{"name":"1Abramson Family Cancer Research Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4032-0562","authenticated-orcid":false,"given":"Amandeep S.","family":"Saini","sequence":"additional","affiliation":[{"name":"3Departments of Pharmacology and Medicine, Section of Hematology and Medical Oncology, The Center for Cancer Research, Boston University School of Medicine, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1260-2351","authenticated-orcid":false,"given":"Ting","family":"Tao","sequence":"additional","affiliation":[{"name":"4National Clinical Research Center for Child Health, National Children's Regional Medical Center, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China."},{"name":"5Cancer Center, Zhejiang University, Hangzhou, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2929-3279","authenticated-orcid":false,"given":"Shizhen","family":"Zhu","sequence":"additional","affiliation":[{"name":"6Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Mayo Clinic Cancer Center, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itzhak","family":"Nissim","sequence":"additional","affiliation":[{"name":"7Division of Genetics and Metabolism, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania."},{"name":"8Department of Pediatrics, Biochemistry, and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7851-8617","authenticated-orcid":false,"given":"A. Thomas","family":"Look","sequence":"additional","affiliation":[{"name":"9Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoliang","family":"Qing","sequence":"additional","affiliation":[{"name":"10Frontier Science Center for Immunology & Metabolism, Medical Research Institute, Wuhan University, Wuhan, Hubei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9106-447X","authenticated-orcid":false,"given":"M. Celeste","family":"Simon","sequence":"additional","affiliation":[{"name":"1Abramson Family Cancer Research Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania."},{"name":"2Department of Cell and Developmental Biology, University of Pennsylvania, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Feng","sequence":"additional","affiliation":[{"name":"3Departments of Pharmacology and Medicine, Section of Hematology and Medical Oncology, The Center for Cancer Research, Boston University School of Medicine, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2021,7,7]]},"reference":[{"key":"2022061706375695400_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrc1014","article-title":"Neuroblastoma: biological insights into a clinical enigma","volume":"3","author":"Brodeur","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"2022061706375695400_bib2","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMra0804577","article-title":"Recent advances in neuroblastoma","volume":"362","author":"Maris","year":"2010","journal-title":"N Engl J Med"},{"key":"2022061706375695400_bib3","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1200\/JCO.2014.59.4648","article-title":"Advances in risk classification and treatment strategies for neuroblastoma","volume":"33","author":"Pinto","year":"2015","journal-title":"J Clin Oncol"},{"key":"2022061706375695400_bib4","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/pbc.24433","article-title":"Children's Oncology Group's 2013 blueprint for research: Neuroblastoma","volume":"60","author":"Park","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"2022061706375695400_bib5","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(07)60983-0","article-title":"Neuroblastoma seminar","volume":"369","author":"Maris","year":"2007","journal-title":"Lancet"},{"key":"2022061706375695400_bib6","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1158\/2159-8290.CD-17-0993","article-title":"MYC drives a subset of high-risk pediatric neuroblastomas and is activated through mechanisms including enhancer hijacking and focal enhancer amplification","volume":"8","author":"Zimmerman","year":"2018","journal-title":"Cancer Discov"},{"key":"2022061706375695400_bib7","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ccr.2012.02.010","article-title":"Activated ALK collaborates with MYCN in neuroblastoma pathogenesis","volume":"21","author":"Zhu","year":"2012","journal-title":"Cancer Cell"},{"key":"2022061706375695400_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ccr.2012.06.001","article-title":"The ALKF1174L mutation potentiates the oncogenic activity of MYCN in neuroblastoma","volume":"22","author":"Berry","year":"2012","journal-title":"Cancer Cell"},{"key":"2022061706375695400_bib9","doi-asserted-by":"crossref","first-page":"141ra91","DOI":"10.1126\/scitranslmed.3003967","article-title":"Targeted expression of mutated ALK induces neuroblastoma in transgenic mice","volume":"4","author":"Heukamp","year":"2012","journal-title":"Sci Transl Med"},{"key":"2022061706375695400_bib10","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1038\/onc.2016.527","article-title":"The pre-rRNA processing factor DEF is rate limiting for the pathogenesis of MYCN-driven neuroblastoma","volume":"36","author":"Tao","year":"2017","journal-title":"Oncogene"},{"key":"2022061706375695400_bib11","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ccell.2017.08.002","article-title":"LMO1 synergizes with MYCN to promote neuroblastoma initiation and metastasis","volume":"32","author":"Zhu","year":"2017","journal-title":"Cancer Cell"},{"key":"2022061706375695400_bib12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature09609","article-title":"Integrative genomics identifies LMO1 as a neuroblastoma oncogene","volume":"469","author":"Wang","year":"2011","journal-title":"Nature"},{"key":"2022061706375695400_bib13","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1158\/2159-8290.CD-15-0507","article-title":"MYC, metabolism, and cancer","volume":"5","author":"Stine","year":"2015","journal-title":"Cancer Discov"},{"key":"2022061706375695400_bib14","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.isci.2019.10.020","article-title":"MYCN-enhanced oxidative and glycolytic metabolism reveals vulnerabilities for targeting neuroblastoma","volume":"21","author":"Oliynyk","year":"2019","journal-title":"iScience"},{"key":"2022061706375695400_bib15","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ccr.2012.09.021","article-title":"ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivation","volume":"22","author":"Qing","year":"2012","journal-title":"Cancer Cell"},{"key":"2022061706375695400_bib16","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1158\/0008-5472.CAN-18-3541","article-title":"Metabolic reprogramming by MYCN confers dependence on the serine-glycine-one-carbon biosynthetic pathway","volume":"79","author":"Xia","year":"2019","journal-title":"Cancer Res"},{"key":"2022061706375695400_bib17","volume-title":"Navigating metabolism","author":"Chandel","year":"2015"},{"key":"2022061706375695400_bib18","doi-asserted-by":"crossref","first-page":"E3434","DOI":"10.1073\/pnas.1617922114","article-title":"PIK3CA mutant tumors depend on oxoglutarate dehydrogenase","volume":"114","author":"Ilic","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061706375695400_bib19","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.celrep.2016.09.052","article-title":"Differential aspartate usage identifies a subset of cancer cells particularly dependent on OGDH","volume":"17","author":"Allen","year":"2016","journal-title":"Cell Rep"},{"key":"2022061706375695400_bib20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nature25003","article-title":"KAT2A coupled with the \u03b1-KGDH complex acts as a histone H3 succinyltransferase","volume":"552","author":"Wang","year":"2017","journal-title":"Nature"},{"key":"2022061706375695400_bib21","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ajhg.2019.02.017","article-title":"Erratum: Recurrent germline DLST mutations in individuals with multiple pheochromocytomas and paragangliomas","volume":"104","author":"Remacha","year":"2019","journal-title":"Am J Hum Genet"},{"key":"2022061706375695400_bib22","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/leu.2016.26","article-title":"The TCA cycle transferase DLST is important for MYC-mediated leukemogenesis","volume":"30","author":"Anderson","year":"2016","journal-title":"Leukemia"},{"key":"2022061706375695400_bib23","volume-title":"The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish (Brachydanio rerio)","author":"Westerfield","year":"1994"},{"key":"2022061706375695400_bib24","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41591-018-0052-4","article-title":"An inhibitor of oxidative phosphorylation exploits cancer vulnerability","volume":"24","author":"Molina","year":"2018","journal-title":"Nat Med"},{"key":"2022061706375695400_bib25","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1186\/s13059-014-0523-y","article-title":"An investigation of biomarkers derived from legacy microarray data for their utility in the RNA-seq era","volume":"15","author":"Su","year":"2014","journal-title":"Genome Biol"},{"key":"2022061706375695400_bib26","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nature10910","article-title":"Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes","volume":"483","author":"Molenaar","year":"2012","journal-title":"Nature"},{"key":"2022061706375695400_bib27","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1038\/onc.2016.527","article-title":"The pre-rRNA processing factor DEF is rate limiting for the pathogenesis of MYCN-driven neuroblastoma","volume":"36","author":"Tao","year":"2017","journal-title":"Oncogene"},{"key":"2022061706375695400_bib28","doi-asserted-by":"crossref","first-page":"12792","DOI":"10.1073\/pnas.0403929101","article-title":"Identification of 315 genes essential for early zebrafish development","volume":"101","author":"Amsterdam","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061706375695400_bib29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1042\/BJ20061209","article-title":"Ca2+, NAD(P)H and membrane potential changes in pancreatic \u03b2-cells by methyl succinate: Comparison with glucose","volume":"403","author":"Heart","year":"2007","journal-title":"Biochem J"},{"key":"2022061706375695400_bib30","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.celrep.2019.03.058","article-title":"Lethal poisoning of cancer cells by respiratory chain inhibition plus dimethyl \u03b1-ketoglutarate","volume":"27","author":"Sica","year":"2019","journal-title":"Cell Rep"},{"key":"2022061706375695400_bib31","doi-asserted-by":"crossref","first-page":"40655","DOI":"10.18632\/oncotarget.5821","article-title":"Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2","volume":"6","author":"Xiao","year":"2015","journal-title":"Oncotarget"},{"key":"2022061706375695400_bib32","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ajhg.2019.02.017","article-title":"Recurrent germline DLST mutations in individuals with multiple pheochromocytomas and paragangliomas","volume":"104","author":"Remacha","year":"2019","journal-title":"Am J Hum Genet"},{"key":"2022061706375695400_bib33","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1158\/2159-8290.CD-13-0696","article-title":"L-2-hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer","volume":"4","author":"Shim","year":"2014","journal-title":"Cancer Discov"},{"key":"2022061706375695400_bib34","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ccr.2012.08.014","article-title":"Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma","volume":"22","author":"Caro","year":"2012","journal-title":"Cancer Cell"},{"key":"2022061706375695400_bib35","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/07357907.2014.907419","article-title":"Importance of glutamine metabolism in leukemia cells by energy production through TCA cycle and by redox homeostasis","volume":"32","author":"Goto","year":"2014","journal-title":"Cancer Invest"},{"key":"2022061706375695400_bib36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ccr.2012.11.020","article-title":"PGC1\u03b1 expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress","volume":"23","author":"Vazquez","year":"2013","journal-title":"Cancer Cell"},{"key":"2022061706375695400_bib37","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nature13611","article-title":"Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function","volume":"514","author":"Viale","year":"2014","journal-title":"Nature"},{"key":"2022061706375695400_bib38","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2015.07.016","article-title":"An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis","volume":"162","author":"Birsoy","year":"2015","journal-title":"Cell"},{"key":"2022061706375695400_bib39","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.cell.2015.07.017","article-title":"Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells","volume":"162","author":"Sullivan","year":"2015","journal-title":"Cell"},{"key":"2022061706375695400_bib40","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ccr.2013.02.003","article-title":"Oncogenic BRAF regulates oxidative metabolism via PGC1\u03b1 and MITF","volume":"23","author":"Haq","year":"2013","journal-title":"Cancer Cell"},{"key":"2022061706375695400_bib41","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ccr.2013.05.003","article-title":"Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells","volume":"23","author":"Roesch","year":"2013","journal-title":"Cancer Cell"},{"key":"2022061706375695400_bib42","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.stem.2010.07.011","article-title":"The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche","volume":"7","author":"Simsek","year":"2010","journal-title":"Cell Stem Cell"},{"key":"2022061706375695400_bib43","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nbt.2530","article-title":"Heterogeneity of tumor-induced gene expression changes in the human metabolic network","volume":"31","author":"Hu","year":"2013","journal-title":"Nat Biotechnol"},{"key":"2022061706375695400_bib44","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41556-020-0477-0","article-title":"Transcriptional diversity and bioenergetic shift in human breast cancer metastasis revealed by single-cell RNA sequencing","volume":"22","author":"Davis","year":"2020","journal-title":"Nat Cell Biol"},{"key":"2022061706375695400_bib45","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1158\/2159-8290.CD-18-1489","article-title":"Molecular profiling reveals unique immune and metabolic features of melanoma brain metastases","volume":"9","author":"Fischer","year":"2019","journal-title":"Cancer Discov"},{"key":"2022061706375695400_bib46","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/ncb3039","article-title":"PGC-1a mediates mitochondrial biogenesis and oxidative phosphorylation to promote metastasis","volume":"16","author":"LeBleu","year":"2014","journal-title":"Nat Cell Biol"},{"key":"2022061706375695400_bib47","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cmet.2017.09.009","article-title":"MYC and MCL1 cooperatively promote chemotherapy-resistant breast cancer stem cells via regulation of mitochondrial oxidative phosphorylation","volume":"26","author":"Lee","year":"2017","journal-title":"Cell Metab"},{"key":"2022061706375695400_bib48","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","article-title":"Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism","volume":"7","author":"Farge","year":"2017","journal-title":"Cancer Discov"},{"key":"2022061706375695400_bib49","doi-asserted-by":"crossref","first-page":"101076","DOI":"10.1016\/j.redox.2018.101076","article-title":"Metabolic reprogramming of oncogene-addicted cancer cells to OXPHOS as a mechanism of drug resistance","volume":"25","author":"Hirpara","year":"2019","journal-title":"Redox Biol"},{"key":"2022061706375695400_bib50","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/nm.4399","article-title":"Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells","volume":"23","author":"Kuntz","year":"2017","journal-title":"Nat Med"},{"key":"2022061706375695400_bib51","doi-asserted-by":"crossref","first-page":"16078","DOI":"10.1038\/nrdp.2016.78","article-title":"Neuroblastoma","volume":"2","author":"Matthay","year":"2016","journal-title":"Nat Rev Dis Prim"},{"key":"2022061706375695400_bib52","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/s41591-018-0019-5","article-title":"Mutations in the SWI\/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer article","volume":"24","author":"Lissanu Deribe","year":"2018","journal-title":"Nat Med"},{"key":"2022061706375695400_bib53","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.1158\/1078-0432.CCR-19-0836","article-title":"A novel mitochondrial inhibitor blocks MAPK pathway and overcomes MAPK inhibitor resistance in melanoma","volume":"25","author":"Gopal","year":"2019","journal-title":"Clin Cancer Res"},{"key":"2022061706375695400_bib54","doi-asserted-by":"crossref","first-page":"eaau1167","DOI":"10.1126\/scitranslmed.aau1167","article-title":"Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma","volume":"11","author":"Zhang","year":"2019","journal-title":"Sci Transl Med"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/81\/17\/4417\/3086394\/4417.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/81\/17\/4417\/3086394\/4417.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T16:26:37Z","timestamp":1655483197000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/81\/17\/4417\/670287\/Metabolic-Enzyme-DLST-Promotes-Tumor-Aggression"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,7]]},"references-count":54,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2021,7,7]]},"published-print":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-20-2153","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22429128","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22429149.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22429137","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22429149","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22429134","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22429131","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22429143","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22429140","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22429152","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22429140.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22429143.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22429137.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22429128.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22429134.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22429152.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22429131.v1","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6513255","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6513255.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,7]]}}}